Timken

TKR · NYSE

Specialty industrial machinery · Industrials · Fiscal year ends Dec 31

Timken reported revenue of $4.6B in the fiscal year ended Dec 2025, up 0.2% from the year before. Operating income was $541M, an operating margin of 11.8%, and net income was $288M. Operating cash flow of $554M less capital expenditure of $148M left free cash flow of $406M. Net debt was $1.5B.

TKR price by TradingView

TKR vs Specialty industrial machinery

All 34 companies in Specialty industrial machinery ›

TKR, better than medianTKR, worseIndustry medianEach peer

Revenue growthlatest year · median 6.2%
0.2%31st of 34
31st of 34
Earnings growthnet income, latest year · median 9.7%
-18.2%25th of 30
25th of 30
Revenue growth, 3 yearscompound a year · median 8.3%
0.6%28th of 33
28th of 33
Earnings growth, 3 yearscompound a year · median 10.6%
-10.9%26th of 27
26th of 27
Operating marginlatest year · median 13.7%
11.8%24th of 33
24th of 33
Margin changevs prior year · median +0.4 pts
-1.6 pts26th of 33
26th of 33
ROCEEBIT ÷ capital employed · median 10.6%
9.4%22nd of 33
22nd of 33
Free cash flow marginFCF ÷ revenue · median 11.4%
8.9%23rd of 32
23rd of 32
Debt ÷ equitylower is safer · median 0.51x
0.60x20th of 31
20th of 31
Cash conversionCFO ÷ net income · median 1.28x
1.92x5th of 34
5th of 34

Ranks among the 34 specialty industrial machinery companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.

Last 5 fiscal years

Revenue and net income

RevenueNet income

Income statement

Figures in US$ millions

Fiscal year	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	4,133	4,497	4,769	4,573	4,582
Cost of revenue	2,984	3,165	3,260	3,132	3,189
Gross profit	1,103	1,288	1,509	1,441	1,393
Selling, general & admin	581	637	741	752	748
Operating income	513	607	657	611	541
Interest expense	58.8	74.6	111	125	110
Pre-tax income	477	551	531	494	416
Income tax	95.1	134	123	119	98.7
Net income	369	407	394	353	288
Diluted EPS	4.79	5.48	5.47	4.99	4.11
Diluted shares	77.0	74.3	72.1	70.8	70.2

Balance sheet

Figures in US$ millions

Fiscal year	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash & equivalents	257	332	419	373	364
Receivables	626	700	672	665	689
Inventory	1,043	1,191	1,229	1,196	1,243
Current assets	2,214	2,504	2,635	2,517	2,601
Net PP&E	1,055	1,207	1,312	1,307	1,358
Goodwill	1,023	1,098	1,370	1,383	1,486
Total assets	5,171	5,772	6,542	6,411	6,677
Payables	430	404	367	322	353
Deferred revenue	3.8	54.3	45.4	41.4	55.7
Current liabilities	897	1,012	1,471	821	922
Short-term debt	11.2	2.7	359	4.3	14.4
Long-term debt	1,411	1,914	1,790	2,050	1,883
Total liabilities	2,793	3,420	3,839	3,427	3,331
Shareholders' equity	2,295	2,268	2,582	2,827	3,185
Backlog (remaining obligations)	234	171	182	153	175

Cash flow

Figures in US$ millions

Fiscal year	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating cash flow	387	464	545	476	554
Capital expenditure	148	178	188	170	148
Free cash flow	239	285	357	306	406
Depreciation & amortisation	168	164	201	222	230
Stock-based compensation	20.2	30.4	30.6	25.9	28.3
Acquisitions	7.5	454	639	167	0.0
Share buybacks	93.0	212	251	40.5	57.4
Dividends paid	92.2	91.7	94.0	96.1	98.3
Dividend per share	1.19	1.23	1.30	1.35	1.39

Key ratios

Figures in US$ millions

Fiscal year	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue growth (YoY)	–	8.8%	6.1%	−4.1%	0.2%
Operating income growth (YoY)	–	18.3%	8.3%	−7.0%	−11.5%
EPS growth (YoY)	–	14.4%	−0.2%	−8.8%	−17.6%
Gross margin	26.7%	28.6%	31.6%	31.5%	30.4%
Operating margin	12.4%	13.5%	13.8%	13.4%	11.8%
Net margin	8.9%	9.1%	8.3%	7.7%	6.3%
Return on equityBlank when equity is negative	16.1%	18.0%	15.3%	12.5%	9.1%
ROCEEBIT ÷ (assets − current liabilities)	12.0%	12.8%	13.0%	10.9%	9.4%
Free cash flow margin	5.8%	6.3%	7.5%	6.7%	8.9%
Cash conversion (CFO ÷ net income)	1.05x	1.14x	1.38x	1.35x	1.92x
Receivable days	55	57	51	53	55
Inventory days	128	137	138	139	142
Payable days	53	47	41	37	40
Interest cover	8.73x	8.14x	5.94x	4.88x	4.90x
Debt ÷ equity	0.62x	0.85x	0.83x	0.73x	0.60x
Net debtDebt − cash & equivalents; excludes investments; negative = net cash	1,165	1,585	1,731	1,681	1,533
Current ratio	2.47x	2.47x	1.79x	3.07x	2.82x

Recent filings

More in Specialty industrial machinery

Want global exposure without picking stocks? See the Technofunda Global Portfolio

Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.

Fiscal year

Dec 2021

Dec 2022

Dec 2023

Dec 2024

Dec 2025

Revenue

4,133

4,497

4,769

4,573

4,582

Cost of revenue

2,984

3,165

3,260

3,132

3,189

Gross profit

1,103

1,288

1,509

1,441

1,393

Selling, general & admin

581

637

741

752

748

Operating income

513

607

657

611

541

Interest expense

58.8

74.6

111

125

110

Pre-tax income

477

551

531

494

416

Income tax

95.1

134

123

119

98.7

Net income

369

407

394

353

288

Diluted EPS

4.79

5.48

5.47

4.99

4.11

Diluted shares

77.0

74.3

72.1

70.8

70.2

Fiscal year

Dec 2021

Dec 2022

Dec 2023

Dec 2024

Dec 2025

Cash & equivalents

257

332

419

373

364

Receivables

626

700

672

665

689

Inventory

1,043

1,191

1,229

1,196

1,243

Current assets

2,214

2,504

2,635

2,517

2,601

Net PP&E

1,055

1,207

1,312

1,307

1,358

Goodwill

1,023

1,098

1,370

1,383

1,486

Total assets

5,171

5,772

6,542

6,411

6,677

Payables

430

404

367

322

353

Deferred revenue

3.8

54.3

45.4

41.4

55.7

Current liabilities

897

1,012

1,471

821

922

Short-term debt

11.2

2.7

359

4.3

14.4

Long-term debt

1,411

1,914

1,790

2,050

1,883

Total liabilities

2,793

3,420

3,839

3,427

3,331

Shareholders' equity

2,295

2,268

2,582

2,827

3,185

Backlog (remaining obligations)

234

171

182

153

175

Fiscal year

Dec 2021

Dec 2022

Dec 2023

Dec 2024

Dec 2025

Operating cash flow

387

464

545

476

554

Capital expenditure

148

178

188

170

148

Free cash flow

239

285

357

306

406

Depreciation & amortisation

168

164

201

222

230

Stock-based compensation

20.2

30.4

30.6

25.9

28.3

Acquisitions

7.5

454

639

167

0.0

Share buybacks

93.0

212

251

40.5

57.4

Dividends paid

92.2

91.7

94.0

96.1

98.3

Dividend per share

1.19

1.23

1.30

1.35

1.39

Fiscal year

Dec 2021

Dec 2022

Dec 2023

Dec 2024

Dec 2025

Revenue growth (YoY)

–

8.8%

6.1%

−4.1%

0.2%

Operating income growth (YoY)

–

18.3%

8.3%

−7.0%

−11.5%

EPS growth (YoY)

–

14.4%

−0.2%

−8.8%

−17.6%

Gross margin

26.7%

28.6%

31.6%

31.5%

30.4%

Operating margin

12.4%

13.5%

13.8%

13.4%

11.8%

Net margin

8.9%

9.1%

8.3%

7.7%

6.3%

Return on equityBlank when equity is negative

16.1%

18.0%

15.3%

12.5%

9.1%

ROCEEBIT ÷ (assets − current liabilities)

12.0%

12.8%

13.0%

10.9%

9.4%

Free cash flow margin

5.8%

6.3%

7.5%

6.7%

8.9%

Cash conversion (CFO ÷ net income)

1.05x

1.14x

1.38x

1.35x

1.92x

Receivable days

Inventory days

128

137

138

139

142

Payable days

Interest cover

8.73x

8.14x

5.94x

4.88x

4.90x

Debt ÷ equity

0.62x

0.85x

0.83x

0.73x

0.60x

Net debtDebt − cash & equivalents; excludes investments; negative = net cash

1,165

1,585

1,731

1,681

1,533

Current ratio

2.47x

1.79x

3.07x

2.82x